The group’s principle activity is to provide research consulting services in drug development. The group’s services include clinical and preclinical studies management, quality assurance, data management, data analysis, scientific report generation, information research, technology assessment, and strategic planning services. Customers served by the group include government and industry clients. The group operates from United States.
